Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Mediators Inflamm

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    January 2017
  1. RAFA H, Benkhelifa S, AitYounes S, Saoula H, et al
    All-Trans Retinoic Acid Modulates TLR4/NF-kappaB Signaling Pathway Targeting TNF-alpha and Nitric Oxide Synthase 2 Expression in Colonic Mucosa during Ulcerative Colitis and Colitis Associated Cancer.
    Mediators Inflamm. 2017;2017:7353252.
    PubMed     Text format     Abstract available


  2. BAO X, Feng Z, Yao J, Li T, et al
    Roles of Dietary Amino Acids and Their Metabolites in Pathogenesis of Inflammatory Bowel Disease.
    Mediators Inflamm. 2017;2017:6869259.
    PubMed     Text format     Abstract available


  3. GUAN Q, Zhang J
    Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease.
    Mediators Inflamm. 2017;2017:4810258.
    PubMed     Text format     Abstract available


  4. DUVOISIN G, Lopez RN, Day AS, Lemberg DA, et al
    Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease.
    Mediators Inflamm. 2017;2017:1936315.
    PubMed     Text format     Abstract available


    January 2016
  5. ABDEL HADI L, Di Vito C, Riboni L
    Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces.
    Mediators Inflamm. 2016;2016:3827684.
    PubMed     Text format     Abstract available


  6. GONG Y, Lin Y, Zhao N, He X, et al
    The Th17/Treg Immune Imbalance in Ulcerative Colitis Disease in a Chinese Han Population.
    Mediators Inflamm. 2016;2016:7089137.
    PubMed     Text format     Abstract available


  7. BERNARDAZZI C, Pego B, de Souza HS
    Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease.
    Mediators Inflamm. 2016;2016:1363818.
    PubMed     Text format     Abstract available


  8. RODRIGUEZ-CANALES M, Jimenez-Rivas R, Canales-Martinez MM, Garcia-Lopez AJ, et al
    Protective Effect of Amphipterygium adstringens Extract on Dextran Sulphate Sodium-Induced Ulcerative Colitis in Mice.
    Mediators Inflamm. 2016;2016:8543561.
    PubMed     Text format     Abstract available


  9. BRYAN PF, Karla C, Edgar Alejandro MT, Sara Elva EP, et al
    Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease.
    Mediators Inflamm. 2016;2016:9890141.
    PubMed     Text format     Abstract available


  10. ZHOU G, Yu L, Yang W, Wu W, et al
    Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease.
    Mediators Inflamm. 2016;2016:2543070.
    PubMed     Text format     Abstract available


  11. PHILLIPS-FARFAN B, Carvajal K, Medina-Torres EA, Espinosa-Padilla SE, et al
    Corrigendum to "Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease".
    Mediators Inflamm. 2016;2016:7267956.
    PubMed     Text format     Abstract available


  12. KHAWAR MB, Abbasi MH, Sheikh N
    IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis.
    Mediators Inflamm. 2016;2016:8413768.
    PubMed     Text format     Abstract available


    January 2015
  13. DE MATTOS BR, Garcia MP, Nogueira JB, Paiatto LN, et al
    Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments.
    Mediators Inflamm. 2015;2015:493012.
    PubMed     Text format     Abstract available


  14. BEKKER P, Ebsworth K, Walters MJ, Berahovich RD, et al
    CCR9 Antagonists in the Treatment of Ulcerative Colitis.
    Mediators Inflamm. 2015;2015:628340.
    PubMed     Text format     Abstract available


  15. MICHIELAN A, D'Inca R
    Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.
    Mediators Inflamm. 2015;2015:628157.
    PubMed     Text format     Abstract available


  16. ALGIERI F, Rodriguez-Nogales A, Rodriguez-Cabezas ME, Risco S, et al
    Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review.
    Mediators Inflamm. 2015;2015:179616.
    PubMed     Text format     Abstract available


  17. SENHAJI N, Kassogue Y, Fahimi M, Serbati N, et al
    Genetic Polymorphisms of Multidrug Resistance Gene-1 (MDR1/ABCB1) and Glutathione S-Transferase Gene and the Risk of Inflammatory Bowel Disease among Moroccan Patients.
    Mediators Inflamm. 2015;2015:248060.
    PubMed     Text format     Abstract available


  18. PARAMEL GV, Sirsjo A, Fransen K
    Role of genetic alterations in the NLRP3 and CARD8 genes in health and disease.
    Mediators Inflamm. 2015;2015:846782.
    PubMed     Text format     Abstract available


  19. YAMAMOTO-FURUSHO JK, Ascano-Gutierrez I, Furuzawa-Carballeda J, Fonseca-Camarillo G, et al
    Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.
    Mediators Inflamm. 2015;2015:659018.
    PubMed     Text format     Abstract available


  20. ENDALE M, Aksoylar HI, Hoebe K
    Central role of gimap5 in maintaining peripheral tolerance and T cell homeostasis in the gut.
    Mediators Inflamm. 2015;2015:436017.
    PubMed     Text format     Abstract available


  21. QIAO YQ, Huang ML, Zheng Q, Wang TR, et al
    CNTNAP3 associated ATG16L1 expression and Crohn's disease.
    Mediators Inflamm. 2015;2015:404185.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: